Article Details
Retrieved on: 2024-03-03 21:58:47
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article details Innoviva, Inc., a biotechnology company trading on NASDAQ (INVA), focusing on its financial metrics, stock performance, and institutional investments. It also touches on Innoviva's pharmaceutical products like Ellipta and Vilanterol. The tags like "Equity securities," "Hedge fund," and "Price-earnings ratio" relate to the financial and stock aspects of the company covered in the article.
Article found on: www.americanbankingnews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here